Details
Stereochemistry | ACHIRAL |
Molecular Formula | C25H19NO3 |
Molecular Weight | 381.4233 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)C1=C(O)C=CC(=C1)N2C(=CC3=C2CCC4=CC=CC=C34)C5=CC=CC=C5
InChI
InChIKey=HAWWPSYXSLJRBO-UHFFFAOYSA-N
InChI=1S/C25H19NO3/c27-24-13-11-18(14-21(24)25(28)29)26-22-12-10-16-6-4-5-9-19(16)20(22)15-23(26)17-7-2-1-3-8-17/h1-9,11,13-15,27H,10,12H2,(H,28,29)
Fendosal (HP 129) is a benzoindole that is 4,5-dihydro-3H-benzo[e]indole in which the nitrogen is substituted by a 3-carboxy-4-hydroxyphenyl group. Fendosal is one of a series of potent non-steroidal anti-inflammatory agents. A non-narcotic analgesic and non-steroidal anti-inflammatory drug, it has greater analgesic and inflammatory responses than aspirin but with less gastrointestinal toxicity. Fendosal 400 mg appears to provide analgesia similar to that of aspirin 650 mg but with a substantially longer duration. Only a few mild side effects were reported.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6344034
The purpose of this study was to characterize the analgesic dose-effect curve of orally administered fendosal, relative to aspirin 650 mg and placebo. A total of 153 patients experiencing moderate to severe pain due to extraction of impacted molar teeth completed this two-part, single-dose, double-blind, randomized trial. In part I, the possible treatments were placebo, aspirin 650 mg, fendosal 100 mg and fendosal 200 mg. In part II, fendosal 400 mg replaced the fendosal 100 mg treatment. Fendosal 100 mg was not an analgesic dose but 200 and 400 mg were on the ascending portion of the dose-effect curve. Fendosal 200 mg was superior to placebo and about equal to aspirin in total effect but not peak effect. Fendosal 400 mg was statistically superior to both fendosal 200 mg and placebo. Fendosal 400 mg appears to provide analgesia similar to that of aspirin 650 mg but with a substantially longer duration.
Route of Administration:
Oral
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C257
Created by
admin on Fri Dec 15 15:14:13 GMT 2023 , Edited by admin on Fri Dec 15 15:14:13 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
40821
Created by
admin on Fri Dec 15 15:14:13 GMT 2023 , Edited by admin on Fri Dec 15 15:14:13 GMT 2023
|
PRIMARY | |||
|
CHEMBL2106146
Created by
admin on Fri Dec 15 15:14:13 GMT 2023 , Edited by admin on Fri Dec 15 15:14:13 GMT 2023
|
PRIMARY | |||
|
SUB07555MIG
Created by
admin on Fri Dec 15 15:14:13 GMT 2023 , Edited by admin on Fri Dec 15 15:14:13 GMT 2023
|
PRIMARY | |||
|
3965
Created by
admin on Fri Dec 15 15:14:13 GMT 2023 , Edited by admin on Fri Dec 15 15:14:13 GMT 2023
|
PRIMARY | |||
|
53597-27-6
Created by
admin on Fri Dec 15 15:14:13 GMT 2023 , Edited by admin on Fri Dec 15 15:14:13 GMT 2023
|
PRIMARY | |||
|
m1158
Created by
admin on Fri Dec 15 15:14:13 GMT 2023 , Edited by admin on Fri Dec 15 15:14:13 GMT 2023
|
PRIMARY | Merck Index | ||
|
135595
Created by
admin on Fri Dec 15 15:14:13 GMT 2023 , Edited by admin on Fri Dec 15 15:14:13 GMT 2023
|
PRIMARY | |||
|
DTXSID80201811
Created by
admin on Fri Dec 15 15:14:13 GMT 2023 , Edited by admin on Fri Dec 15 15:14:13 GMT 2023
|
PRIMARY | |||
|
3224
Created by
admin on Fri Dec 15 15:14:13 GMT 2023 , Edited by admin on Fri Dec 15 15:14:13 GMT 2023
|
PRIMARY | |||
|
9Z709558TZ
Created by
admin on Fri Dec 15 15:14:13 GMT 2023 , Edited by admin on Fri Dec 15 15:14:13 GMT 2023
|
PRIMARY | |||
|
100000081270
Created by
admin on Fri Dec 15 15:14:13 GMT 2023 , Edited by admin on Fri Dec 15 15:14:13 GMT 2023
|
PRIMARY | |||
|
C80549
Created by
admin on Fri Dec 15 15:14:13 GMT 2023 , Edited by admin on Fri Dec 15 15:14:13 GMT 2023
|
PRIMARY | |||
|
351522
Created by
admin on Fri Dec 15 15:14:13 GMT 2023 , Edited by admin on Fri Dec 15 15:14:13 GMT 2023
|
PRIMARY |
ACTIVE MOIETY